PolyPeptide Group AG

SWX:PPGN Stock Report

Market Cap: CHF 943.3m

PolyPeptide Group Future Growth

Future criteria checks 4/6

PolyPeptide Group is forecast to grow earnings and revenue by 64.2% and 13.2% per annum respectively. EPS is expected to grow by 65.2% per annum. Return on equity is forecast to be 6.1% in 3 years.

Key information

64.2%

Earnings growth rate

65.2%

EPS growth rate

Life Sciences earnings growth22.3%
Revenue growth rate13.2%
Future return on equity6.1%
Analyst coverage

Low

Last updated15 Nov 2024

Recent future growth updates

Recent updates

PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 19% Below Its Share Price

Nov 11
PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 19% Below Its Share Price

PolyPeptide Group (VTX:PPGN) Is Making Moderate Use Of Debt

Oct 21
PolyPeptide Group (VTX:PPGN) Is Making Moderate Use Of Debt

Sentiment Still Eluding PolyPeptide Group AG (VTX:PPGN)

Sep 16
Sentiment Still Eluding PolyPeptide Group AG (VTX:PPGN)

Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?

Jun 19
Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?

Further Upside For PolyPeptide Group AG (VTX:PPGN) Shares Could Introduce Price Risks After 33% Bounce

Mar 14
Further Upside For PolyPeptide Group AG (VTX:PPGN) Shares Could Introduce Price Risks After 33% Bounce

PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 99% Above Its Share Price

Mar 13
PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 99% Above Its Share Price

PolyPeptide Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 18
PolyPeptide Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors Shouldn't Be Too Comfortable With PolyPeptide Group's (VTX:PPGN) Robust Earnings

Mar 23
Investors Shouldn't Be Too Comfortable With PolyPeptide Group's (VTX:PPGN) Robust Earnings

Earnings and Revenue Growth Forecasts

SWX:PPGN - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202648337-14554
12/31/202541513-29324
12/31/2024348-12-51114
6/30/2024324-293085N/A
3/31/2024322-40561N/A
12/31/2023320-51-2036N/A
9/30/2023300-44-621N/A
6/30/2023279-37-104-35N/A
3/31/2023280-14-89-15N/A
12/31/20222818-735N/A
9/30/202228120-747N/A
6/30/202228133-759N/A
3/31/202228140-4833N/A
12/31/202128247-2057N/A
9/30/202127748-467N/A
6/30/2021271481377N/A
3/31/2021248401063N/A
12/31/202022431649N/A
12/31/2019203263656N/A
12/31/201818124523N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PPGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.3%).

Earnings vs Market: PPGN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: PPGN is expected to become profitable in the next 3 years.

Revenue vs Market: PPGN's revenue (13.2% per year) is forecast to grow faster than the Swiss market (4.2% per year).

High Growth Revenue: PPGN's revenue (13.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PPGN's Return on Equity is forecast to be low in 3 years time (6.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 22:17
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PolyPeptide Group AG is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Markus MayerBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research